
Yuwell Oxygen Concentrator
In 2024, Yuwell's Stationary Oxygen Concentrator have been registered with the TGA in Australia (ARTG ID 443510), officially gaining access to the Australian market.
User Hotline: +61 1300 848 102
In 2024, Yuwell's Stationary Oxygen Concentrator have been registered with the TGA in Australia (ARTG ID 443510), officially gaining access to the Australian market.
This is a service description. Add more detail about this service, such as benefits, appearance, components and value
Flow Range: 0.5~5L /min
Oxygen Concentration: 95.5%-87%
Maximum Limited Pressure: 70kPa
Sound Level: 48 dB(A)
Input Power: 350VA
Minimum Operating Time: 30minutes
G.W./N.W: 17.5/15.5kg
Size: 48.5"34"60cm
Flow range: 0.5~5L/min
Oxygen concentration: 95.5%-87%
Maximum outlet pressure: 70kPa
Sound level: 42dB(A)
Nebulizing rate: 0.1mL/min(9F-5BW only) In
put power: 400VA
Minimum operating time: 30minutes
G.W./N.W: 20.5/17.5kg
Size: 48"40"63cm
Maximum Flow: 750ml/min
(Equivalent Continuous Oxygen Supply: 3.75L/min)
Oxygen Concentration (Measured after warm up 30minutes): >=90%
Maximum Outlet Pressure: 150kPa
Sound Level: <= 55dB
Minimum Operating Time: 30minutes
Operational temperature: 5°C~40°C
Altitude: 0 to 5000m
G.W./N.W: 4.5kgs/2.2kg
Size: 32"32"21cm
Mode: CPAP/Auto PAP
Color: White/Black
Pressure: 4-20 cmH2O
Noise: 28 dBA±2dBA
Dimensions: 285x155x125 mm
G.W./N.W: 3.6/2.4kg
Size: 40x27x17.5cm
Mode: CPAP/Auto PAP
Color: Black
Pressure: 4-20 cmH2O
Noise: 27 dBA±2dBA
Screen Size: 3.5-inch
Dimensions: 285x155x125 mm
G.W./N.W: 3.7/2.4kg
Size: 41×31×18cm
Heated Tube
SD Card/WiFi Data Transfer
Mode: CPAP/Auto PAP
Color: Black
Pressure: 4-20 cmH2O
Noise: 27 dBA±2dBA
Screen Size: 4.3-inch
Dimensions: 285x155x125 mm
G.W./N.W: 3.7/2.4kg
Size: 41×31×18cm
Heated Tube
SD Card/WiFi Data Transfer
Comprehensive and professional respiratory therapy analysis system based on security-assured cloud server for patient management. Optional WiFi module or 4G Cellular module are required for this function. Currently available on BreathCare II and BreathCare III.